VA Connecticut Healthcare System
Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive Disorder
Psilocybin for the Treatment of Migraine Headache
Repeat Dosing of Psilocybin in Migraine Headache
Effects of Psilocybin in Concussion Headache
Psilocybin for the Treatment of Cluster Headache
Open Label Ketamine Treatment for Major Depressive Disorder in Veterans
Pilot Study of ORG 25935 Modulation of Ketamine-induced Behavioral and Cognitive Effects in Healthy Male Subjects
Ketamine for Depression and Alcohol Dependence
Examining the Impact of Sirolimus on Ketamine's Antidepressant Effects
CAP-Ketamine for Antidepressant Resistant PTSD
Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder
The Effects of Ketamine and Guanfacine on Working Memory in Healthy Subjects
THC and Ketamine Effects in Humans: Relation to Neural Oscillations and Psychosis
A Study To Examine The Effects Of PF-04958242 On Ketamine-Induced Cognitive Impairment In Healthy Volunteers
Parallel Effects of Schizophrenia and N-methyl-D-aspartate (NMDA) Antagonism
Ketamine/Placebo Family History Positive Study
Nicotinic Modulation of Schizophrenia-like Information Processing Deficits in Healthy Subjects
N-acetylcysteine and NMDA Antagonist Interactions
GABA-glutamate Interactions and Psychosis
Fixed Order, Open-Label, Dose-Escalation Study of DMT in Humans